For Immediate Release: December 04, 2025 The U.S. Food and Drug Administration today approved a new indication for Breyanzi (Lisocabtagene maraleucel) as the first Chimeric Antigen Receptor (CAR) T… [+2843 chars]
No comments yet. Be the first to comment!
Your trusted source for breaking news, in-depth analysis, and comprehensive coverage of today's most important stories.
Get daily updates on breaking news, exclusive interviews, and special features delivered to your inbox.
Have a news tip or want to get in touch with our editorial team? We're here to help.
Plot C3-C Jaypee Wishtown Sector 129 Noida Uttar Pradesh 201304 India